New study aims to boost HIV prevention in vulnerable women
NCT ID NCT06835751
First seen Jan 05, 2026 · Last updated Jun 15, 2026 · Updated 15 times
Summary
This study tests two counseling programs to help 200 women who use drugs in Tanzania start and continue taking PrEP, a daily pill that prevents HIV. One group gets basic support, another gets extra mental health counseling. The goal is to find the best way to overcome barriers like stigma and depression so more women can protect themselves from HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Muhimbili University of Health and Allied Sciences
Dar es Salaam, Tanzania
Conditions
Explore the condition pages connected to this study.